These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38045857)

  • 21. (1)H NMR-based metabolomics study on a goldfish model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lu Z; Wang J; Li M; Liu Q; Wei D; Yang M; Kong L
    Chem Biol Interact; 2014 Nov; 223():18-26. PubMed ID: 25242684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
    Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of gut microbiota with sort-chain fatty acids and inflammatory cytokines in diabetic patients with cognitive impairment: A cross-sectional, non-controlled study.
    Du Y; Li X; An Y; Song Y; Lu Y
    Front Nutr; 2022; 9():930626. PubMed ID: 35938126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease.
    He X; Qian Y; Xu S; Zhang Y; Mo C; Guo W; Yang X; Xiao Q
    J Parkinsons Dis; 2021; 11(3):1167-1176. PubMed ID: 33935107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Short-Chain Fatty Acids in Patients With Parkinson's Disease.
    Shin C; Lim Y; Lim H; Ahn TB
    Mov Disord; 2020 Jun; 35(6):1021-1027. PubMed ID: 32154946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A highly sensitive, simple, and fast gas chromatography-mass spectrometry method for the quantification of serum short-chain fatty acids and their potential features in central obesity.
    Rahman MN; Diantini A; Fattah M; Barliana MI; Wijaya A
    Anal Bioanal Chem; 2021 Nov; 413(27):6837-6844. PubMed ID: 34533599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
    Jiang Z; Wang X; Zhang H; Yin J; Zhao P; Yin Q; Wang Z
    MedComm (2020); 2023 Jun; 4(3):e268. PubMed ID: 37200942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and comparison of short chain fatty acids composition in gut diseases.
    Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
    World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Overview on Fecal Branched Short-Chain Fatty Acids Along Human Life and as Related With Body Mass Index: Associated Dietary and Anthropometric Factors.
    Rios-Covian D; González S; Nogacka AM; Arboleya S; Salazar N; Gueimonde M; de Los Reyes-Gavilán CG
    Front Microbiol; 2020; 11():973. PubMed ID: 32547507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-Chain Fatty Acids Modulate Metabolic Pathways and Membrane Lipids in
    Trautmann A; Schleicher L; Deusch S; Gätgens J; Steuber J; Seifert J
    Proteomes; 2020 Oct; 8(4):. PubMed ID: 33081314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson's disease via the AKT signaling pathway.
    Huang T; Shi H; Xu Y; Ji L
    Neuroreport; 2021 Feb; 32(3):244-251. PubMed ID: 33470765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
    Qiao CM; Sun MF; Jia XB; Li Y; Zhang BP; Zhao LP; Shi Y; Zhou ZL; Zhu YL; Cui C; Shen YQ
    Neurochem Res; 2020 Sep; 45(9):2128-2142. PubMed ID: 32556930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
    van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
    J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harms.
    Li XZ; Zhang SN; Lu F; Liu CF; Wang Y; Bai Y; Wang N; Liu SM
    Phytomedicine; 2013 Oct; 20(13):1219-29. PubMed ID: 23830815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Concentrations of Short-Chain Fatty Acids in Active and Recovered Anorexia Nervosa.
    Xu J; Landberg R; Lavebratt C; Bulik CM; Landén M; Nilsson IAK
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.
    Nomura M; Nagatomo R; Doi K; Shimizu J; Baba K; Saito T; Matsumoto S; Inoue K; Muto M
    JAMA Netw Open; 2020 Apr; 3(4):e202895. PubMed ID: 32297948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.